The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk

Archive ouverte

Caussy, C. | Aubin, A. | Loomba, R.

Edité par CCSD ; Current Medicine Group -

International audience. PURPOSE OF REVIEW: Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are strongly associated. Both also associate with an increased risk of cardiovascular disease (CVD). RECENT FINDINGS: Several studies have provided evidence that NAFLD could be an independent CVD risk factor. Given the strong association between NAFLD and T2DM, assessing the independent CV effect of these two conditions remains challenging. However, patients with T2DM and NAFLD exhibit higher risk of CVD compared with T2DM without NAFLD suggesting a potential synergistic increase of CV risk in patients with both T2DM and NAFLD supported by several shared pathophysiological pathways. Several anti-diabetic therapies have shown beneficial effect on both NAFLD and CVD. Patients with T2DM and NAFLD should be considered at high risk of CVD and could benefit from more intensive CV prevention. Additional long-term follow-up is needed to demonstrate that the treatment of NAFLD effectively reduces the risk of CVD.

Consulter en ligne

Suggestions

Du même auteur

The grade of obesity affects the noninvasive diagnosis of advanced fibrosis in individuals with MASLD

Archive ouverte | Chouik, Y. | CCSD

International audience. OBJECTIVE: Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with obesity. We aimed to assess the impact of obesity on the performance of different noninv...

Multifunctional dietary interventions, low-grade inflammation and cardiometabolic profile: a scoping review

Archive ouverte | Hornero-Ramirez, H. | CCSD

BACKGROUND: Growing evidence highlights the significant impact of diet to modify low-grade inflammation closely linked to cardiometabolic profile. Multifunctionnal diets, combining several compounds have been shown to beneficially...

Collagen Formation Assessed by N-Terminal Propeptide of Type 3 Procollagen Is a Heritable Trait and Is Associated With Liver Fibrosis Assessed by Magnetic Resonance Elastography

Archive ouverte | Caussy, C. | CCSD

International audience. N-terminal propeptide of type 3 procollagen (PRO-C3) is a biomarker of liver fibrosis in nonalcoholic fatty liver disease (NAFLD). This study examines the association between PRO-C3 concentra...

Chargement des enrichissements...